Omega Dia Share Price (ODX)

The deals are going through at 12.25. So institutions selling and buying relatively big numbers

Home straight hopefully, no doubt someone will want to buy it just hope we get a really good price and not the first or second offer

Also if this was classed as a biotech company we would now be valued at a 100 milion inmo

Totally agree dibs.thats why I invested

A gaze into the future. I've seen this as a potential take over target in the past from a larger diagnostics player. I see that as a prospect again. If we look at Finncaps prediction of potential annual demand of c.6m tests - that equals around £25m pa revenue at around a 60% margin for Visitect CD4 tests alone - not even including Food Intolerance and Allergy potential. The company has a MC of just £18m - woefully undervalued based on these prospects.

CD4 is no longer a pipedream the project is reaching commercialisation after years of development. Its a unique product - nothing else like it on the market - no competitor. Its a potential cash cow with NGO's being a reliable consistent buyer for possibly years to come.

IMHO on the basis of Visitect CD4 alone its future projected valuation on a VERY conservative basis is 3 x Annual Sales = £75m. Thats a share price of 50p. I accept its not worth that yet but I am talking about projections 3/5 years ahead.

I'm not even bothering to factor in the value of Food Intolerance but, if you did, we are looking at nearer a £100m valuation. I'd be interested in other peoples thoughts. This may seem like ramping at first glance but I believe the figures are realistic.

I believe the Visitect CD4 project has been almost entirely derisked. Its already received EPRD approval and it seems to me highly unlikely that having achieved that status it will not get WHO Prerequisite and once it does we are truly over the line and off to the races. And its only around 6 months away.